WORCESTER, Mass. - Mustang Bio , Inc. (NASDAQ:MBIO), a biopharmaceutical company engaged in the development of cell therapies for cancer treatment, has announced the pricing of a public offering ...

Uncertainty about U.S. trade tariffs and persistent portfolio outflows have hurt the rupee over the last two months and made ...

Relmada purchases Sepranolone, a Phase 2b ready asset, for the treatment of Tourette syndrome (TS) and other compulsion-related conditions from Asarina Pharma AB Phase 2a results signaled improvement ...

The New England Journal of Medicine has published results from the Phase II eNRGy trial for Bizengri (zenocutuzumab), a novel cancer med from Merus. Bizengri is the first approved treatment for people ...

LUND, SE / ACCESS Newswire / February 6, 2025 / Alligator Bioscience (STO:ATORX)FDA feedback validates the clinical development strategy and Phase 3 designFDA feedback confirms that the toxicology pac ...

Swiss biotech BioVersys, which develops treatments for serious infections caused by drug resistant bacteria, has completed its initial public offering with an implied market valuation of 213 million ...

HelloHero, a leading provider of technology-powered mental health and behavioral care, has secured a multi-million dollar investment package from Decathlon Capital Partners. The funding will enable ...

The federal office that enforces civil rights at school across the nation has been ordered to prioritize complaints of ...

Partner Therapeutics, Inc. (PTx), a private, fully-integrated biotechnology company announced today that the New England Journal ...

The United States Postal Service on Wednrsday said it would start accepting packages from China and Hong Kong again, just ...

Indaptus Therapeutics, Inc. (Nasdaq: INDP) ("Indaptus" or the "Company"), a clinical-stage biotechnology company pioneering innovative cancer and viral infection ...

The USPS did not provide a reason for the suspension but said in a statement Tuesday the flow of letters would not be affected.